FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

15 letters match. Newest first.

  1. Aidance Scientific, Inc.

    FDA: Aidance Scientific's Terragen HG Formula, sold for genital sores, is an unapproved new drug.

    High risk
  2. OrganiCare, LLC / OrganiCare Nature’s Science, LLC

    FDA told OrganiCare of Austin, Texas that its HClear for him and FemiClear Genital Herpes Symptoms ointments are unapproved new drugs.

    High risk
  3. Bioactive Services USA, LLC / Herstat Inc.

    FDA warns Bioactive Services/Herstat that Herstat GST is an unapproved new drug for genital sores.

    High risk
  4. Woodbine Products Company Inc.

    Inspection found Woodbine Products, an Ohio OTC drug maker, failed to test incoming ingredients like glycerin and propylene glycol for identity.

    High risk
  5. Leading Edge Health Inc.

    FDA told Leading Edge Health its Erectin Stimulating Gel and VigRX Delay Wipes are unapproved new drugs based on claims on its website.

    Medium
  6. DermaRite Industries, LLC

    DermaRite failed CGMP and sold unapproved, misbranded OTC topical drugs, FDA says.

    High risk
  7. Evi Labs LLC

    FDA warns Evi Labs over OTC drug manufacturing failures, including an antiperspirant lot above the aluminum chlorohydrate limit.

    High risk
  8. Choice All Natural, Inc. dba Om Botanical

    FDA warns Om Botanical of Apex, NC over filthy manufacturing, an unapproved rash cream, and lapsed FDA registration.

    High risk
  9. Soliteint Kozmetikai KFT

    Hungarian contract maker Soliteint Kozmetikai failed to test OTC pain-relief drugs and ingredients, FDA says; U.S. production halted.

    High risk
  10. Clinical Resolution Laboratory Inc.

    FDA warned Clinical Resolution Laboratory in Brea, CA, about CGMP failures and unapproved OTC drugs.

    High risk
  11. Holographic Health, Inc.

    FDA says Holographic Health marketed 14 products as unapproved new drugs through disease claims on its website.

    High risk
  12. Blue Poppy Enterprises Inc

    Blue Poppy Enterprises sold herbal products with disease-treatment claims as unapproved new drugs, FDA says.

    High risk
  13. McDaniel Water, LLC

    FDA told McDaniel Water its Black Indian Salve is an unapproved new drug because it is a corrosive topical product sold with disease-treatment claims.

    High risk
  14. Sanit Technologies, LLC dba Durisan

    FDA says Sanit Technologies (Durisan) released contaminated alcohol-free hand sanitizer, including Burkholderia cepacia, made with contaminated water.

    High risk
  15. Disinfect & Shield

    FDA warned Disinfect & Shield that its non-alcohol hand sanitizer was an unapproved drug sold with COVID-19 and long-lasting efficacy claims.

    High risk